Conference Presentations
Addiction Medicine Review Course 2008
- Alcohol / Anthony Albanese, MD
- Benzodiazepines/Sedative Hypnotics / Steve Juergens, MD
- Substance Abuse Treatment / Richard Rawson, PhD
- Confidentiality Issues / H. Westley Clark, MD, JD, MPH
- Neurobiology of Addiction: Springboard to New Treatments / George Koob, PhD
- Future of Genomic Medicine in the Addiction Field / Charles O'Brien, MD, PhD
- Nicotine / David P. L. Sachs, MD
- The Role of 12-Step Programs / Steve Ey, MD
- Opioid Pharmacology and Pain Treatment / Steven Richeimer, MD
- Opioid Pharmacotherapies / Judith Martin, MD
- Trends in Prescription Drug Use and Misuse / H. Westley Clark, MD, JD, MPH
- Epidemiology of Addiction / Mary-Lynn Brecht, PhD
- Stimulants: Cocaine and Methamphetamine / Steven L. Batki, MD
- Infectious Diseases / Kristen Ochoa, MD
- Dual Diagnosis: Co-Occurring Mental Illness and Substance Use Disorders / Steven L. Batki, MD
- Drug Testing for the Clinician / H. Westley Clark, MD, JD, MPH
- Club Drugs / Karen Miotto, MD
- Inhalants and Hallucinogens / Charles Grob, MD
- Substance Abuse, Pregnancy, and Fetal Development / M. Lynn Yonekura, MD
- Cannabis / Timmen Cermak, MD
- Guideline for Physicians Working in Narcotic Treatment Programs (Handout from the workshop: Methadone Maintenance Update 2008)
- Coding to Optimize Reimbursement for Substance Abuse Treatment
Coding to Optimize Reimbursement (Handouts) E&M Local Medical Review • Specialty Exam/Psychiatry
Addiction Medicine Review Course 2006
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nicotine Dependence: Improving Your Treatment Skills / Judith Prochaska, PhD, MPH, Assistant Adjunct Professor, UC San Francisco Department of Psychiatry and Steven Fremont, MD, Associate Physician, UCSF Department of Psychiatry, Medical Director, Medical Director, Dual Diagnosis Inpatient Unit, Alta Bates, Summitt Medical Center, Berkeley
-
-
-
-
Addiction Medicine State of the Art 2005
- A Role of the Brain Stress Systems in the "Dark Side" of Addiction (PDF) / George F. Koob, PhD
- Stress and Addiction Relapse: Psychobiological Mechanisms and Clinical Implications (PDF) / Rajita Sinha, PhD
- Hormonal Responses to Acute and Chronic Stress: A Role for Comfort Food (PDF) / Mary Dallman, PhD
- Mechanisms of Food Craving and Drug Addiction: Similarities and Differences (PDF) / Dana M. Small, PhD
- Chronic Stress: Effects on Eating and Cell Aging (PDF) / Elissa Epel, PhD
- Smoking Impairs Recovery from Alcohol: New Evidence (PDF) / Timothy C. Durazzo, PhD
- The Endocannabinoid System and the Regulation of Pain and Emotion (PDF)/ Daniele Piomelli, PhD
- Cannabinoid CB1 Receptor Antagonists: The New Option in the Treatment of Obesity, Metabolic Syndrome and Addiction (PDF) / Daniela Cota, MD
- A Chronic Care Perspective (PDF) / A. Thomas McLellan, PhD
- Defining the Continuum (PDF) / Constance Weisner, DrPH, MSW
- DBT and the Art of Engagement (PDF) / Elisabeth P. Bellows, MD
- The Role of Public Health in Addiction Medicine (PDF) / Robert Brewer, MD
- Illicit Drug Use Among Adolescents (PDF) / Amy Khan, MD, MPH
- Community & School Based Interventions Update (PDF) / Jeffery Wilkins, MD
- Alcohol Markers (PDF) / Denise Greene, MD
- Provigil, Lunestra and Topamax (PDF) / Denise Greene, MD
- Connection Through Suffering (PDF) / Michael Kearney, MD
- Opioids and Pain Pathways (PDF) / Peggy Compton, RN, PhD
- Emerging Insights from Research Models of Pain and Addiction (PDF) / Christopher J. Evans, PhD
Dual Diagnosis (Pre-Conference Workshop)
Dialectical Behavior Therapy An Experiential Workshop on Engagement and Confrontation (Powerpoint) / Elisabeth P. Bellows, MD and Michael Hutchinson, LMFT (Pre-Conference Workshop)
Chronic Pain: Clinical Tools for the Addiction Medicine Specialist: Application to Fibromyalgia, Back Pain, and Headache (Pre-Conference Workshop)
Addiction Medicine Review Course 2004
- Co-Occurring Addiction and Severe Mental Disorders / Richard Ries, MD
- Co-Occurring Addiction and Mild/Moderate Mental Disorders / Richard Ries, MD
- Genetics of Alcoholism and Addiction / Marc Schuckit, MD
- Linking Science and Treatment in Addiction Medicine / Sean Koon, MD
- 12-Step Programs / Garrett O’Connor, MD
- Benzodiazepines / Mel Pohl, MD
- Infectious Diseases / Diana Sylvestre, MD
- Treatment of Dual Diagnosis Patients / John Tsuang, MD
- Stimulants / Richard Rawson, PhD
- Neonatal and Women's Issues / Carol Archie, MD
- The Family in Recovery / Sue Jackson, MS, MFT
- Medical Review Officer / David Smith, MD
Addiction Medicine State of the Art 2003
- Opioids: Should Tolerance Affect our Management? -- Pamela Pierce Palmer, MD, PhD, Director, Pain Management Center, UCSF
- The Thin Edge of the Wedge: Acceptance, Change, and Behavior Therapy in the Treatment of Addiction -- Elisabeth Bellows, MD, Private Practice of Psychiatry, Menlo Park, CA
- The Impact of Research on the Care of Addicted Patients: A NIDA Update -- Nora Volkow, MD, Director, National Institute on Drug Abuse
- Looking for the Neural Basis of Motivation -- Howard Fields, MD, PhD, Director, Wheeler Center for the Neurobiology of Addiction, UCSF
- Is There a Common Neural Substrate for Analgesia and Reward? -- Robert W. Gear, DDS, PhD, Assistant Clinical Professor, Department of Oral and Maxillofacial Surgery, UCSF
- Forget it! The Role of Alpha-2 Agonists in Fear Conditioning -- M. Frances Davies, PhD, Research Associate and Director of Faculty Development, Stanford University VAPAHCS
- Medications Development for Treatment of Drug Abuse: A Path from Clinical Trial to Market -- Donald R. Wesson, MD, Consultant, CNS Medication Development; Chair ASAM Committee on Medications Development, Oakland, CA
- Advances in the Genetics of Addiction -- Raymond White, PhD, Director, Ernest Gallo Clinic & Research Center, UCSF
- Hot Topics in Neuroimaging Addictive Disorders -- Nora Volkow, MD, Director, National Institute on Drug Abuse
- Alcohol-Induced Brain Injury and its Reversal with Abstinence: Clinical Magnetic Resonance Studies -- Dieter J. Meyerhoff, Dr.rer.nat, Associate Professor of Radiology, UCSF; Senior Research Associate, VA Medical Center, SF
- Ibogaine Analogues: Drug Development for Addictive Disorders -- Stanley Glick, PhD, MD, Professor and Director, The Center for Neuropharmacology and Neuroscience, Albany Medical Center, Albany, NY
- Co-Occurring Disorders: Overview of Latest Research and Clinical Implications -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
- Contingency Management of Disability Benefits for Severely Mentally Ill Persons with Substance Disorders -- Richard Ries, MD, Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle, WA
- Bipolar Disorder and Substance Abuse: Impact and Treatment Implications-- Mark Frye, MD, Associate Professor of Psychiatry, David Geffen School of Medicine at UCLA; Director, UCLA, Bipolar Disorder Research Program, Los Angeles, CA
- Integrating 12-Step Spirituality, 21st Century Pharmacotherapy and Dual Diagnosis Concepts -- Garrett O'Connor, MD, Associate Clinical Professor of Psychiatry, UCLA; Consultant, Betty Ford Center, Rancho Mirage, CA
- Post-traumatic Stress Disorder in the Addicted: What We Know, What We Need to Know: An Interactive Workshop -- Elisa Triffleman, MD, Senior Research Scientist, The Public Health Institute, Oakland, CA; Research Affiliate, Yale University School of Medicine
- Integrating Dual Recovery Therapy and Medications for Co-Occurring Disorders -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
- Dialectical Behavioral Therapy in the Treatment of Bulimia and Binge Eating Disorder: Research and Practical Applications -- Deborah Safer, MD, Associate Director of Residency Training Program in Psychiatry, Staff Psychiatrist and Research Scientist, Stanford University, Palo Alto
- Treatment Needs of Women with Co-Occurring Disorders -- Joan Zweben, PhD, Exec. Dir., 14th St. Clinic & East Bay Community Recovery Project, Oakland; Clinical Prof. of Psychiatry, UCS
- Why Are So Many Dually Disordered Patients So Over-Medicated and What Are the Implications of This? -- Richard Ries, MD, Prof. of Psychiatry Univ. of Washington Medical School, Director of Outpatient Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle
- Culture and Infection: Understanding Risk-Taking Among Heroin Users in San Francisco -- Daniel H. Ciccarone, MD, MPH, Assistant Professor, Department of Family and Community Medicine, and Department of Anthropology, History and Social Medicine, UCSF